133 related articles for article (PubMed ID: 26405464)
21. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
22. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
Schaefer JF; Vollmar J; Schick F; Vonthein R; Seemann MD; Aebert H; Dierkesmann R; Friedel G; Claussen CD
Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
[TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
24. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
[TBL] [Abstract][Full Text] [Related]
26. Peripheral washout sign on contrast-enhanced MR images of the breast.
Sherif H; Mahfouz AE; Oellinger H; Hadijuana J; Blohmer JU; Taupitz M; Felix R; Hamm B
Radiology; 1997 Oct; 205(1):209-13. PubMed ID: 9314987
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging features of idiopathic granulomatous mastitis: is there any contribution of diffusion-weighted imaging in the differential diagnosis?
Yilmaz R; Demir AA; Kaplan A; Sahin D; Ozkurt E; Dursun M; Acunas G
Radiol Med; 2016 Nov; 121(11):857-866. PubMed ID: 27406630
[TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced MR angiography of the breast: Evaluation of ipsilateral increased vascularity and adjacent vessel sign in the characterization of breast lesions.
Kul S; Cansu A; Alhan E; Dinc H; Reis A; Çan G
AJR Am J Roentgenol; 2010 Nov; 195(5):1250-4. PubMed ID: 20966336
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
[TBL] [Abstract][Full Text] [Related]
30. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
31. MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study.
Sardanelli F; Rescinito G; Giordano GD; Calabrese M; Parodi RC
J Comput Assist Tomogr; 2000; 24(5):724-31. PubMed ID: 11045693
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.
Kim ES; Chang JH; Choi HS; Kim J; Lee SK
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1055-8. PubMed ID: 20110372
[TBL] [Abstract][Full Text] [Related]
33. Whole body MRI with DWI in people with NF1 and Schwannomatosis: Are qualitative and quantitative imaging features of peripheral lesions comparable to localized MRI?
Debs P; Fayad LM; Romo CG; Ahlawat S
Eur J Radiol; 2023 May; 162():110802. PubMed ID: 37001256
[TBL] [Abstract][Full Text] [Related]
34. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
35. Type 2 dynamic curves: A diagnostic dilemma.
Karavas E; Ece B; Aydın S
World J Radiol; 2022 Jul; 14(7):229-237. PubMed ID: 36160627
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions.
Stomper PC; Winston JS; Herman S; Klippenstein DL; Arredondo MA; Blumenson LE
Breast Cancer Res Treat; 1997 Aug; 45(1):39-46. PubMed ID: 9285115
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.
Amarosa AR; McKellop J; Klautau Leite AP; Moccaldi M; Clendenen TV; Babb JS; Zeleniuch-Jacquotte A; Moy L; Kim S
Radiology; 2013 Aug; 268(2):356-65. PubMed ID: 23657893
[TBL] [Abstract][Full Text] [Related]
38. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
39. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
Partridge SC; Mullins CD; Kurland BF; Allain MD; DeMartini WB; Eby PR; Lehman CD
AJR Am J Roentgenol; 2010 Jun; 194(6):1664-73. PubMed ID: 20489111
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]